In addition, association studies between genetic variants of the HTR1A, as well as solute carrier family 6, member 4 (SLC6A4) genes and clinical outcomes in schizophrenia, have shown that rs6295 and 5-HTTLPR polymorphisms significantly influence clinical symptoms in schizophrenia [106]. This evidence concerns the gene SLC6A4 and schizophrenia.